+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults



Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults



Pediatric Infectious Disease Journal 37(7): 673-677



Perinatally HIV-infected (PHIV+) adolescents and young adults (AYA) are at risk for suboptimal antiretroviral therapy (ART) adherence and mental health and substance use problems that, in HIV-infected adults, predict nonadherence. Studies on the relationship between psychiatric and substance use disorders (SUD) and adherence among PHIV+ AYA are limited, but may be important for informing evidence-based interventions to promote adherence. Data were analyzed from 3 annual follow-up interviews (FU2-FU4, N = 179) in a longitudinal study of PHIV+ AYA. Psychiatric disorders (anxiety, disruptive behavior, mood and SUD) were assessed with the Diagnostic Interview Schedule for Children. Adherence was self-reported missed ART doses within the past week. Viral load (VL) results were abstracted from medical charts. Multiple logistic regression analyzed cross-sectional associations between psychiatric disorders and (1) missed ART dose and (2) VL > 1000 copies/mL. Multiple linear regression assessed associations between psychiatric disorders and proportion of VL values >1000 copies/mL over time. At FU2, 53% of PHIV+ AYA had any psychiatric disorder, 35% missed an ART dose in the past week and 47% had a VL > 1000 copies/mL. At FU2, behavioral disorders were associated with missed dose (P = 0.009) and VL > 1000 (P = 0.019), and mood disorders were associated with missed dose (P = 0.041). At FU4, behavioral disorders were associated with missed dose (P = 0.009). Behavioral disorders (P = 0.041), SUD (P = 0.016) and any disorder (P = 0.008) at FU2 were associated with higher proportion of VLs >1000 across FU2-FU4. Addressing psychiatric disorder and SUD among PHIV+ AYA may improve ART adherence outcomes in this population. Targeted interventions should be developed and tested.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065446685

Download citation: RISBibTeXText

PMID: 29227462

DOI: 10.1097/inf.0000000000001866


Related references

Episodic medication adherence in adolescents and young adults with perinatally acquired HIV: a within-participants approach. Aids Care 28(Suppl. 1): 68-75, 2016

Treatment outcomes in perinatally infected HIV-positive adolescents and young adults after ≥10 years on antiretroviral therapy. South African Medical Journal 109(1): 27-34, 2018

Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria. International Journal of Std and Aids 27(11): 938-949, 2016

Qualitative Comparison of Barriers to Antiretroviral Medication Adherence Among Perinatally and Behaviorally HIV-Infected Youth. Qualitative Health Research 27(8): 1177-1189, 2017

Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil. Journal of Adolescent Health 59(3): 305-310, 2016

Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand. Plos one 12(2): E0172392, 2017

A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults. Aids and Behavior 17(1): 41-60, 2013

Highly active antiretroviral therapy adherence among perinatally infected HIV adolescents at a teaching hospital in Ghana. Aids Care 30(9): 1144-1146, 2018

Association of Adolescent- and Caregiver-Reported Antiretroviral Therapy Adherence with HIV Viral Load Among Perinatally-infected South African Adolescents. Aids and Behavior 22(3): 909-917, 2018

Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV. Journal of Adolescent Health 51(3): 242-251, 2012

Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. Aids Care 13(1): 27-40, 2001

Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults. Journal of the Pediatric Infectious Diseases Society 4(1): 63-66, 2015

Sexual and reproductive health in a UK cohort of young adults perinatally infected with HIV. Sexually Transmitted Infections 89(5): 392-394, 2013

Transition in adult care for HIV perinatally infected adolescents and young adults. Archives de Pediatrie 14(6): 741-743, 2007

Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy. Journal of Allergy and Clinical Immunology 118(2): 324-330, 2006